Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
66.91
-1.26 (-1.85%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Liquidia Revenue
Liquidia had revenue of $171.68M in the quarter ending June 30, 2026, with 1,842.73% growth. This brings the company's revenue in the last twelve months to $450.91M, up 2,233.65% year-over-year. In the year 2025, Liquidia had annual revenue of $158.32M with 1,031.18% growth.
Revenue (ttm)
$450.91M
Revenue Growth
+2,233.65%
P/S Ratio
13.28
Revenue / Employee
$2,087,532
Employees
216
Market Cap
5.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.32M | 144.32M | 1,031.18% |
| Dec 31, 2024 | 14.00M | -3.49M | -19.97% |
| Dec 31, 2023 | 17.49M | 1.55M | 9.75% |
| Dec 31, 2022 | 15.94M | 3.08M | 23.98% |
| Dec 31, 2021 | 12.85M | 12.11M | 1,637.77% |
| Dec 31, 2020 | 739.63K | -7.33M | -90.84% |
| Dec 31, 2019 | 8.07M | 5.37M | 198.20% |
| Dec 31, 2018 | 2.71M | -4.55M | -62.70% |
| Dec 31, 2017 | 7.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 5.02B |
| Dr. Reddy's Laboratories | 3.50B |
| Amneal Pharmaceuticals | 3.12B |
| Hims & Hers Health | 2.58B |
| Alkermes | 1.67B |
| Lantheus Holdings | 1.56B |
| Indivior Pharmaceuticals | 1.33B |
| Kiniksa Pharmaceuticals International, | 840.85M |
LQDA News
- 21 hours ago - Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - GlobeNewsWire
- 15 days ago - Liquidia reports Q2 EPS 74c, consensus 84c - TheFly
- 16 days ago - Liquidia downgraded to Market Perform from Outperform at LifeSci Capital - TheFly
- 16 days ago - Liquidia price target raised to $108 from $62 at Wells Fargo - TheFly
- 16 days ago - Liquidia price target raised to $92 from $79 at BofA - TheFly
- 16 days ago - Liquidia price target raised to $106 from $68 at Raymond James - TheFly
- 20 days ago - Liquidia Earnings Call Transcript: Q2 2026 - Transcripts
- 20 days ago - Liquidia Earnings release: Q2 2026 - Filings